Form 4: Tandem Diabetes Care Executive Susan Morrison Reports Stock Transactions
SEC Form 4
EVP & Chief Admin. Officer Susan Morrison reports the vesting of restricted stock units and subsequent withholding of shares for tax obligations.
Summary
- On August 15, 2024, Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care Inc., reported transactions involving common stock and restricted stock units (RSUs).
- Morrison acquired shares through the vesting of RSUs granted under the company's 2013 and 2023 Stock Incentive Plans.
- A total of 163, 474, and 1,503 shares were acquired through RSU vesting.
- Shares were withheld by Tandem Diabetes Care to satisfy tax withholding requirements on the vesting of these RSUs, with a price of $43.82 per share.
- Following these transactions, Morrison directly owns 23,372 shares of Tandem Diabetes Care common stock and 10,522 RSUs.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing represents routine stock transactions related to executive compensation. There is no indication of unusual activity or cause for concern.
Positives
- The vesting of RSUs indicates that performance milestones have been met, which is generally a positive sign.
Industry Context
Executive stock transactions are a normal part of corporate governance and compensation practices in the medical device industry. These transactions can provide insights into management's perspective on the company's performance and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including RSUs, are common in the medical device industry to align management's interests with those of shareholders.
- Companies like Medtronic, Abbott, and Boston Scientific also utilize stock-based compensation as part of their executive pay structures.
- The vesting schedules and terms of Tandem Diabetes Care's RSU grants appear to be consistent with industry norms.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may view the vesting of RSUs as a sign of management's commitment and alignment with company goals.
Key Dates
| Date | Description |
|---|---|
| May 18, 2021 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| May 15, 2022 | First vesting date (25%) for RSUs awarded on May 18, 2021. |
| May 25, 2022 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| May 15, 2023 | First vesting date (33%) for RSUs awarded on May 25, 2022. |
| May 25, 2023 | Date of RSU award pursuant to the 2023 Long-Term Incentive Plan. |
| May 15, 2024 | First vesting date (33%) for RSUs awarded on May 25, 2023. |
| August 15, 2024 | Date of reported transactions (RSU vesting and tax withholding). |
| August 19, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.